| Mitotic Spindle as Therapeutic Target for Tetraploid Cancer Cells | Mohamed JEMAA | 205–208 |
| Pain Ladder of the Palliative Care Center for Cancer Pain Management. A New Perspective from Turkey Based on EFIC Standards | Serbülent Gökhan BEYAZ,Gürkan DEMİR,İlhan HACIBEKİROĞLU | 209–216 |
| Extended Duration of Adjuvant Temozolomide inGlioblastoma Multiforme – A Review of Trials | Deep Shankar PRUTHI, Puneet NAGPAL, Manish PANDEY | 217–221 |
| Impact of Gender on the Prognosis of Patients withHepatocellular Carcinoma After Palliative Therapy | Lei LIU, Hao Tian LIU, Xiu Mei LIANG, Xu LIU, Zhu Jian DENG, Liang MA, Bangde XIANG, Jian Hong ZHONG, De Jia HUANG | 222–227 |
| A Meta-Analysis for Association of Cyclooxygenase-2 Polymorphisms with Susceptibility to Prostate Cancer | Fatemeh ASADIAN,Hadi MALEKI,Sepideh SETAYESH,Seyed Alireza DASTGHEIB,Mohamad ZARE,Saeed KARGAR,Seyed Hossein SHAKER,Mahta MAZAHERI,Hossein NEAMATZADEH | 228–238 |
| Artificial Intelligence and Machine Learning in Oncology: Historical Overview of Documents Indexed in the Web of Science Database | Ibrahim Hussein MUSA,Ibrahim ZAMIT,Marvellous OKEKE,Tosin Yinka AKINTUNDE,Taha Hussein MUSA | 239–248 |
| Alterations of Glutathione and GSTM1 Mutation Induce Tumor Metastasis and Invasion Via EMT Pathway in Breast Cancer Patients | Arshad ALI,Ayaz ALI,Shafiq AHMAD | 249–259 |
| Dialister in Microbiome of Cancer Patients: A SystematicReview and Meta-Analysis | Mehmet DEMİRCİ | 260–272 |
| Identification of a Novel Mutation in Hereditary Breast Cancerin a Family with Wide Spectrum of Atypical Malignancies | Tatiana KEKEEVA, Amulang SHIKEEVA, Alexander TANAS, Vladimir STRELNIKOV | 273–278 |
| COVID-19 Vaccination in Algeria: The Starting Race | Mohamed LOUNIS | 279–280 |